Document is current

Article History

Received: 16 September 2019

Accepted: 23 July 2020

First Online: 13 August 2020

Ethics approval and consent to participate

: This prospectively designed study (ExternalRef removed: NCT03098303) was approved by an independent ethics committee (Le Comité de Protection des Personnes Sud-Méditerranée I; reference number: 14–72). As per French legislation and ethics committee approval, no written inform consent was required. Patients’ consent was implied upon the completion of the questionnaire.

: N.A.

: None of the authors reports interests related to the present work.Dr. Laurie PAHUS reports consultancies for Astra Zeneca and Chiesi pharmaceuticals.Dr. Carey Suehs has no conflict of interest to declare.Dr. Laurence Halimi reports industry-sponsored grants and lecturer activities for GlaxoSmithKline, Actelion and Novartis.Dr. Arnaud Bourdin reports industry-sponsored grants from AstraZeneca-MedImmune, Boehringer-Ingelheim, Cephalon/Teva, GlaxoSmithKline, Novartis, Sanofi-Regeneron; consultancies for AstraZeneca-MedImmune, Boehringer-Ingelheim, GlaxoSmithKline, Novartis, Regeneron- Sanofi, Med-in-Cell, Actelion, Merck, Roche, Chiesi; investigator/Co-investigator activities for trials promoted by AstraZeneca-MedImmune, Boehringer-Ingelheim, GlaxoSmithKline, Novartis, Regeneron- Sanofi, Chiesi, Actelion, Merck, Roche, Vertex, Galapagos; no personal financial support from a non-commercial source; no personal relationships with tobacco industry entities; no off-label disclosures.Dr. Pascal Chanez, as an advisory board member, consultant or lecturer, has previously received honoraria or grants from Boehringer Ingeheim, Almirall, Centocor, GSK, MSD, Astra Zeneca, Novartis, Teva, Chiesi, Shering Plough and Aix Marseille University.Dr. Dany Jaffuel reports advisory board membership, meetings and participation as an investigator in clinical trials sponsored by ASTRA ZENECA, AIR LIQUIDE, APARD, BASTIDE, BOEHRINGER INGELHEIM, BOSTON SCIENTIFIC, LOEWENSTEIN-MEDICAL, PHILIPS, RESMED, SEFAM, VIVISOL.Dr. Julie Marciano has no conflict of interest to declare.Dr. Anne-Sophie Gamez has no conflict of interest to declare.Dr. Isabelle Vachier has no conflict of interest to declare.Dr. Nicolas Molinari has no conflict of interest to declare.For all authors reporting conflict of interest, none of the latter participated in or had any influence over the present analysis or manuscript.